Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals…
Sector
Healthcare
Exchange
NYSE
Country
US
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Alto Neuroscience (ANRO) Analysis Tools & Insights
Income Statement